Sihuan Pharmaceutical Holdings Group Ltd.
SHPHF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $6,621 | $3,322 | $4,385 | $5,057 |
| - Cash | $3,599 | $3,622 | $4,010 | $4,480 |
| + Debt | $1,027 | $974 | $1,125 | $1,257 |
| Enterprise Value | $4,049 | $674 | $1,500 | $1,833 |
| Revenue | $1,146 | $951 | $950 | $805 |
| % Growth | 20.5% | 0.2% | 18% | – |
| Gross Profit | $757 | $633 | $609 | $548 |
| % Margin | 66.1% | 66.6% | 64.1% | 68.1% |
| EBITDA | $304 | -$280 | $114 | -$129 |
| % Margin | 26.5% | -29.4% | 12% | -16% |
| Net Income | $103 | -$183 | -$33 | -$4 |
| % Margin | 9% | -19.3% | -3.5% | -0.5% |
| EPS Diluted | 0.011 | -0.02 | -0.004 | -0.001 |
| % Growth | 156.6% | -450% | -620% | – |
| Operating Cash Flow | -$95 | $207 | $36 | $171 |
| Capital Expenditures | -$27 | -$22 | -$48 | -$52 |
| Free Cash Flow | -$122 | $185 | -$12 | $120 |